Literature DB >> 1750796

Epidemiology of scleroderma.

A J Silman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1750796      PMCID： PMC1033319          DOI： 10.1136/ard.50.suppl_4.846

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  95 in total

1.  Systemic scleroderma, A clinical study of 727 cases.

Authors:  D L TUFFANELLI; R K WINKELMANN
Journal:  Arch Dermatol       Date:  1961-09

2.  Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations.

Authors:  L D ERASMUS
Journal:  S Afr J Lab Clin Med       Date:  1957-09

3.  A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease.

Authors:  A J Barnett; M H Miller; G O Littlejohn
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

4.  An epidemiological study of scleroderma in the West Midlands.

Authors:  A Silman; S Jannini; D Symmons; P Bacon
Journal:  Br J Rheumatol       Date:  1988-08

5.  Survival with scleroderma. II. A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients.

Authors:  T A Medsger; A T Masi
Journal:  J Chronic Dis       Date:  1973-10

6.  [Incidence of diffuse disorders of the connective tissue with special reference to systemic lupus erythematosus in a selected district in the years 1961-1969].

Authors:  K Bosmanský; D Zitnan; T Urbánek; V Svec
Journal:  Fysiatr Revmatol Vestn       Date:  1971-12

7.  Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response.

Authors:  C G Kallenberg; J M Van der Voort-Beelen; J D'Amaro; T H The
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

8.  Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979.

Authors:  C J Michet; C H McKenna; L R Elveback; R A Kaslow; L T Kurland
Journal:  Mayo Clin Proc       Date:  1985-02       Impact factor: 7.616

9.  Familial clustering of scleroderma spectrum disease.

Authors:  A R McGregor; A Watson; E Yunis; J P Pandey; K Takehara; J T Tidwell; A Ruggieri; R M Silver; E C LeRoy; H R Maricq
Journal:  Am J Med       Date:  1988-06       Impact factor: 4.965

10.  Toxic oil syndrome: a syndrome with features overlapping those of various forms of scleroderma.

Authors:  A Alonso-Ruiz; A C Zea-Mendoza; J M Salazar-Vallinas; A Rocamora-Ripoll; J Beltrán-Gutiérrez
Journal:  Semin Arthritis Rheum       Date:  1986-02       Impact factor: 5.532
View more
  15 in total

1.  Evaluation of liver function tests in scleroderma patients.

Authors:  Gehan Ibrahim Abdelrazek Salem; Awni Ali Abdulrahman
Journal:  Rheumatol Int       Date:  2011-06-05       Impact factor: 2.631

2.  Exposure to chemicals and systemic sclerosis.

Authors:  L Czirják; Z Csiki; Z Nagy; E Tóth
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

3.  Scleroderma and malignancy: an epidemiological study.

Authors:  A K Rosenthal; J K McLaughlin; M S Linet; I Persson
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

4.  Systemic sclerosis mortality in the United States: 1979-1998.

Authors:  Eswar Krishnan; Daniel E Furst
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 5.  Murine mercury-induced autoimmunity: a model of chemically related autoimmunity in humans.

Authors:  L M Bagenstose; P Salgame; M Monestier
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

6.  Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies.

Authors:  Nezam Altorok; Pei-Suen Tsou; Patrick Coit; Dinesh Khanna; Amr H Sawalha
Journal:  Ann Rheum Dis       Date:  2014-05-08       Impact factor: 19.103

7.  Systemic sclerosis in Iceland. A nationwide epidemiological study.

Authors:  A J Geirsson; K Steinsson; S Guthmundsson; V Sigurthsson
Journal:  Ann Rheum Dis       Date:  1994-08       Impact factor: 19.103

8.  Mercury-induced autoimmunity in the absence of IL-4.

Authors:  L M Bagenstose; P Salgame; M Monestier
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

Review 9.  Epidemiology of organic solvents and connective tissue disease.

Authors:  D H Garabrant; C Dumas
Journal:  Arthritis Res       Date:  1999-12-01

10.  Factors associated with development of gastrointestinal problems in patients with scleroderma: a protocol for a systematic review.

Authors:  Brian Younho Hong; Raymond Giang; Lawrence Mbuagbaw; Maggie Larche; Lehana Thabane
Journal:  Syst Rev       Date:  2014-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.